The coronavirus reached every corner of the world, and although its adverse effects vary from country to country, the collective hope centers on a single issue: vaccines.
However, the inoculation to be received will depend on the nation in which the person resides, as well as the necessary requirements for it to be administered.
Despite this and the doubts generated by the accelerated In the vaccine manufacturing process, pharmaceutical companies have gone ahead, presenting their respective variants of the immunizer.
At least 36 million people in the world have already been vaccinated against the coronavirus, with the United States, China and the United Kingdom being the ones that have administered the most inoculations to their citizens.
First the American Government announced that they would give priority to healthcare workers and nursing home residents.
In addition, the United States Centers for Disease Control and Prevention (CDC) recommended that those next to be vaccinated should be “essential front-line workers” such as firefighters and police officers.
The CDC also suggested that they continue with those over 75 that are not in care centers; people between 65 and 74 years old; those with comorbidity factors against the virus, between the age range of 16 to 64, and other essential workers, such as people who work in transportation and food service.
For this they have used the vaccines developed by Moderna and that of Pfizer-BionTech, which is the only one that has the approval of the World Health Organization (WHO), both approved by the US Food and Drug Administration. (FDA) in mid-December of last year.
The Asian giant has been inoculating its population with three vaccines developed within its territory, Sinovac, Sinopharm and CanSino.
China, like the United States, planned to inoculate specific parts of its citizens, first vaccinating medical personnel and agents of its police force.
Similarly there are officials, firefighters, undertakers, transporters, nursing home staff, customs and border control agents, as well as people who need to travel abroad for studies or work.
These would be the first to benefit from the massive vaccination campaign that they had announced, which aims to inoculate some 50 million citizens before the Chinese New Year, according to the Hong Kong newspaper South China Morning Post, which begins on February 12.
The United Kingdom revealed its vaccination plan during the week, with the goal of vaccinating 15 million people by February this year, using the products of Pfizer-BionTech, Moderna and AstraZeneca, all approved by the British National Health Service ( NHS, in English).
The UK Government places importance on the elderly who reside in nursing homes, along with the people who care for them.
This group also includes health professionals and social workers, in addition to citizens over 70 years of age.
From the end of February onwards, they will do the same with those over 50 years old and with those who present comorbidity factors against COVID-19, and are within the age range of 16 to 64.
In the same way, they affirmed that people would receive vaccines in local GP offices and community pharmacies, in hospitals and at mass vaccination sites in all the countries that make up the UK.
According to the BBC, in England there are about 1,000 GP centers, 200 community pharmacies, 206 hospital centers and seven mass vaccination centers are operating.
However, problems with inoculation processes did not take long to appear, something that was expected due to the demand that exists for vaccines.
According to AP reports, the expansion of this process in the United States has caused long bottlenecks and failures in computer systems.
An example of this occurred in Mississippi, where the local health department stopped accepting appointments the same day it began, due to a “monumental spike” in requests, causing people to have to wait hours just to make their appointment. to get vaccinated.
Those who succeeded were rated as lucky, as many were taken off the website due to technical problems and had to start the process over.
Something similar happened in the state of Georgia, where phone lines collapsed from the volume of incoming calls.
There is also the particularity that in the US they are autonomous to a certain extent, so the guideline to vaccinate older people is malleable, since each locality chooses from what age it will be a “priority person”, varying between 65, 70 or more years.
Last Thursday, New Jersey expanded its vaccination program to include people between the ages of 16 and 65 with certain medical conditions, including 2 million smokers, who are more likely to have health complications, something that does not happen in all state.
Another drawback has been that one of the most prominent vaccines, that of Pfizer-BionTech, has had problems producing its own, to the point that developers had to temporarily reduce the shipment it had agreed to with Canada.
The Canadian Minister of Public Services, Anita Anand, was the one who shared the news, explaining last Friday that the expansion of Pfizer’s vaccine production for its European customers is reducing shipments to all countries that receive the vaccine produced in its European facility.